Man Group
KURA icon

Man Group’s Kura Oncology KURA Stock Holding History

Man Group’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.75M Sell
432,908
-42,119
-9% -$397K 0.01% 1162
2026
Q1 		$3.86M Buy
475,027
+233,488
+97% +$2.01M 0.01% 1285
2025
Q4 		$2.51M Sell
241,539
-216,725
-47% -$2.27M ﹤0.01% 1371
2025
Q3 		$4.06M Sell
458,264
-64,124
-12% -$457K 0.01% 1151
2025
Q2 		$3.01M Buy
522,388
+366,324
+235% +$2.24M 0.01% 1261
2025
Q1 		$1.03M Buy
156,064
+137,359
+734% +$1.07M ﹤0.01% 1573
2024
Q4 		$163K Buy
+18,705
New +$269K ﹤0.01% 1897
2021
Q1 		– Sell
-17,158
Closed -$560K – 1927
2020
Q4 		$560K Sell
17,158
-7,418
-30% -$261K ﹤0.01% 1523
2020
Q3 		$753K Buy
24,576
+6,179
+34% +$136K ﹤0.01% 1446
2020
Q2 		$300K Buy
18,397
+4,687
+34% +$67.6K ﹤0.01% 1542
2020
Q1 		$136K Sell
13,710
-92,229
-87% -$1.06M ﹤0.01% 1498
2019
Q4 		$1.46M Sell
105,939
-147,446
-58% -$2.18M ﹤0.01% 1415
2019
Q3 		$3.84M Sell
253,385
-42,542
-14% -$757K 0.01% 991
2019
Q2 		$5.83M Buy
295,927
+198,870
+205% +$3.3M 0.02% 885
2019
Q1 		$1.61M Buy
+97,057
New +$1.5M 0.01% 1422

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Man Group's KURA Position: Q2 2026 in Review

Man Group reduced its Kura Oncology (KURA) stake by 8.9% in Q2 2026, selling an estimated $397K and leaving 432,908 shares worth $4.75M. The position accounts for 0.01% of the portfolio, ranked #1162.

Man Group first reported a position in KURA in Q1 2019 and has held it in 15 quarters since. The position peaked at $5.83M in Q2 2019. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Man Group held 432,908 shares of Kura Oncology worth $4.75M as of Q2 2026.
  • Man Group sold 42,119 Kura Oncology shares in Q2 2026, an estimated $397K.
  • Kura Oncology made up 0.01% of Man Group's portfolio in Q2 2026, its #1162 holding.
  • Man Group first reported a position in Kura Oncology in Q1 2019 and has held it in 15 quarters since.
  • Man Group's Kura Oncology position peaked at $5.83M in Q2 2019.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.